Tuesday, September 7th, 2010

 
Title:
Is There a Need for Positron Emission Tomography Imaging to Stage the N0 Neck in T1-T2 Squamous Cell Carcinoma of the Oral Cavity or Oropharynx?
Authors:  Ursula Schroeder, MD; Markus Dietlein, MD; Claus Wittekindt, MD; Monika Ortmann, MD; Hartmut Stuetzer, MD; Julia Vent, MD; Markus Jungehuelsing, MD; Barbara Krug, MD
  Objectives: We assess whether negative findings on computed tomography (CT), magnetic resonance imaging (MRI), and/or 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) may contribute to the decision-making process of elective neck dissection (eND) in patients with squamous cell carcinoma of the oral cavity or the oropharynx (oSCC) staged cT1-T2 cN0 cM0.
Methods: We interpreted CT, MRI, and 18FDG-PET images separately, after combining the data of CT with those of 18FDG-PET and the data of MRI with those of 18FDG-PET. Each set of results was then compared with the histopathologic results of ipsilateral or bilateral eND in a prospective, blinded study.
Results: The histopathologic examination of 594 lymph nodes revealed 4 metastases less than 4 mm in diameter and 3 micrometastases (less than 2 mm) in 6 of 17 patients. On CT, MRI, and 18FDG-PET, respectively, 5, 5, and 0 cases were true-malignant (true positives) and 4, 10, and 1 cases were false-malignant (false positives). The accuracy was not enhanced by fusing CT with 18FDG-PET or MRI with 18FDG-PET.
Conclusions: The detectability threshold of occult metastases appears to be below the spatial and contrast resolution of CT, MRI, and 18FDG-PET. The decision for eND in patients with cT1-T2 cN0 cM0 oSCC cannot be based upon crosssectional imaging at the resolutions currently available.
(Ann Otol Rhinol Laryngol 2008;117:854-863.)
Keywords:  elective neck dissection, fluorodeoxyglucose positron emission tomography, head and neck squamous cell carcinoma, imaging, occult metastasis
 
  Acrobat Reader 8.0 is recommeded to properly view and print the article.
Reader can be downloaded here: